Publications:

BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma.

Genome Medicine

Shrestha, Raunak R; Nabavi, Noushin N; Lin, Yen-Yi YY; Mo, Fan F; Anderson, Shawn S; Volik, Stanislav S; Adomat, Hans H HH; Lin, Dong D; Xue, Hui H; Dong, Xin X; Shukin, Robert R; Bell, Robert H RH; McConeghy, Brian B; Haegert, Anne A; Brahmbhatt, Sonal S; Li, Estelle E; Oo, Htoo Zarni HZ; Hurtado-Coll, Antonio A; Fazli, Ladan L; Zhou, Joshua J; McConnell, Yarrow Y; McCart, Andrea A; Lowy, Andrew A; Morin, Gregg B GB; Chen, Tianhui T; Daugaard, Mads M; Sahinalp, S Cenk SC; Hach, Faraz F; Le Bihan, Stephane S; Gleave, Martin E ME; Wang, Yuzhuo Y; Churg, Andrew A; Collins, Colin C CC

Publication Date: 2019-02-18

Variant appearance in text: EPHB2: Y800X

PubMed Link: 30777124

Variant Present in the following documents:

• 13073_2019_620_MOESM2_ESM.xlsx, sheet 3

View BVdb publication page

BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma.

Journal Of Translational Medicine

Alakus, Hakan H; Yost, Shawn E SE; Woo, Brian B; French, Randall R; Lin, Grace Y GY; Jepsen, Kristen K; Frazer, Kelly A KA; Lowy, Andrew M AM; Harismendy, Olivier O

Publication Date: 2015-04-16

Variant appearance in text: EPHB2: Y800X

PubMed Link: 25889843

Variant Present in the following documents:

• 12967_2015_485_MOESM1_ESM.xlsx, sheet 5

View BVdb publication page